Certain proteins found in the human brain have long been known to be critical to controlling how brain cells communicate with ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...

The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday.

Yet due to technical limitations and the delicate nature of studying human brain tissue, scientists have lacked a complete ...